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The latency-associated nuclear antigen (LANA) of Kaposi’s sarcoma-associated herpesvirus
functions as an origin-binding protein (OBP) and transcriptional regulator. LANA binds the
terminal repeats via the C-terminal DNA-binding domain (DBD) to support latent DNA replication.
To date, the structure of LANA has not been solved. Sequence alignments among OBPs of
gammaherpesviruses have revealed that the C terminus of LANA is structurally related to EBNA1,
the OBP of Epstein–Barr virus. Based on secondary structure predictions for LANADBD and
published structures of EBNA1DBD, this study used bioinformatics tools to model a putative
structure for LANADBD bound to DNA. To validate the predicted model, 38 mutants targeting the
most conserved motifs, namely three a-helices and a conserved proline loop, were constructed
and functionally tested. In agreement with data for EBNA1, residues in helices 1 and 2 mainly
contributed to sequence-specific DNA binding and replication activity, whilst mutations in helix 3
affected replication activity and multimer formation. Additionally, several mutants were isolated
with discordant phenotypes, which may aid further studies into LANA function. In summary, these
data suggest that the secondary and tertiary structures of LANA and EBNA1 DBDs are conserved
and are critical for (i) sequence-specific DNA binding, (ii) multimer formation, (iii) LANA-
dependent transcriptional repression, and (iv) DNA replication.
INTRODUCTION
Kaposi’s sarcoma-associated herpesvirus (KSHV; human
herpesvirus 8) is a DNA tumour virus associated with
Kaposi’s sarcoma, primary effusion lymphomas and a
plasmablastic variety of multicentric Castleman’s disease
(Cesarmanetal., 1995; Chang etal.,1 9 9 4 ;S o u l i e retal., 1995).
The latency-associated nuclear antigen (LANA), encoded by
ORF73, interacts with multiple cellular proteins to affect
various signal transduction pathways (Gao et al., 1996; Kedes
et al., 1996). LANA also functions as an origin-binding
protein (OBP) by binding to the viral latent origin, and
recruits the host cellular replication machinery to ensure
replication of viral episomes during S phase. Additionally,
LANA tethers viral genomes to mitotic chromosomes via its
N-terminal chromosome-binding motif, thereby contributing
to episomal maintenance (Ballestas & Kaye, 2001; Ballestas
et al., 1999; Barbera et al., 2006; Cotter & Robertson, 1999;
Garber et al., 2002; Hu et al., 2002; You et al., 2006).
The C-terminal LANA DNA-binding domain (LANADBD,
aa 775–1003; Garber et al., 2001) binds cooperatively to
LANA binding sites 1 and 2 (LBS1/2) within viral terminal
repeats (TRs) for replication of TR-containing plasmids
(Garber et al., 2001, 2002; Hu et al., 2002). LANA
predominantly forms dimers, and the dimerization domain
has been mapped to the LANADBD (Schwam et al., 2000),
which also has partial replication activity (Hu et al., 2002).
LANAand EBNA1, the OBP of Epstein–Barr virus (EBV), are
functional homologues with respect to DNA binding and
supporting DNA replication by recruitment of cellular origin
recognition complex proteins. Both proteins form dimers in
solution and bind to two sites within their respective origins
of replication in a cooperative manner (Lim et al., 2002;
Schepers et al., 2001; Stedman et al., 2004; Verma et al., 2006).
A supplementary figure and table are available with the online version of
this paper.
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binding domain (DBD) has been determined to date. In
contrast, crystal structures of EBNA1 in the presence and
absence of DNA (Bochkarev et al., 1995, 1996) and E2, the
OBP of human papillomavirus (HPV) (Hegde et al., 1992),
have been solved. Although EBNA1 and E2 share very
limited primary sequence homology and are encoded by
different classes of DNA tumour virus, their DBDs revealed
a common core domain structure. The core domain
consists of a series of interspersed b-sheets, which form a
b-barrel within the dimer interface, a proline loop, which
interacts with cellular proteins, and three a-helices, which
make direct or indirect contacts to DNA and stabilize
higher-order multimers (Bochkarev et al., 1995, 1996;
Ceccarelli & Frappier, 2000). To gain insights into the
possible structure of the LANADBD in the absence of a
crystal structure, we performed detailed sequence align-
ments among the LANADBDs of different rhadinoviruses
and performed bioinformatics-based modelling to predict
a potential structure. We investigated our model by
mutational analysis and by functional testing of mutants
targeting residues most conserved between different
LANADBDs and EBNA1DBD.
RESULTS
High evolutionary conservation of LANADBDsi n
gammaherpesviruses and bioinformatics-based
predicted structure of KSHV LANADBD
Grundhoff & Ganem (2003) first noted a limited secondary
structure homology between the C termini of LANA and
EBNA1. Furthermore, sequencing LANA from a retro-
peritoneal fibromatosis-associated herpesvirus variant
from Macaca nemestrina (RFHVMn) and Macaca nemes-
trina rhadinovirus 2 (MneRV2) revealed that the C-
terminal amino acids of their LANAs showed the strongest
sequence conservation (Burnside et al., 2006). To analyse
these homologies further, we performed amino acid
alignment among the LANADBDs of KSHV, RFHVMn
and rhesus monkey rhadinovirus (RRV) and the EBV
EBNA1DBD using the bioinformatics programs PRALINE,
3D-PSSM and T-Coffee (Fig. 1 and Table 1). This analysis
revealed that KSHV LANADBD had greater than 50%
similarity to the DBDs of RFHVMn and RRV. Although
EBNA1DBD had less than 16% overall amino acid sequence
identity to LANADBDs (Table 1), there was significant
structural similarity such as the presence of three a-helices,
as noted previously (Grundhoff & Ganem, 2003). In
addition, we found a proline-rich loop motif that was
conserved between KSHV LANADBD (
930PHPGPDQSP
938)
and EBV EBNA1DBD (
545PGPGPQPGP
553) (Fig. 1b), which
is important for the protein–protein interactions of EBNA1
(Bochkarev et al., 1996). We also noted that, among KSHV,
RFHVMn and RRV, residues within the a-helices were
more highly conserved than the surrounding residues (Fig.
1a). Based on these observations, we performed bioinfor-
matics modelling to predict the KSHV LANADBD structure,
a common approach for related proteins for which crystals
cannot easily be obtained (Hantz et al., 2009; Hass et al.,
2008; Purta et al., 2005).
KSHV LANADBD residues 868–960 were modelled with the
3D-JIGSAW modelling tool (Bates et al., 2001) using the
EBNA1DBD structure (PDB accession no. 1B3T) as
template (Bochkarev et al., 1996). The LANADBD residues
929–939 did not have defined coordinates after 3D-JIGSAW
analysis and were modelled using ModLoop (Fiser & Sali,
2003). Despite the relatively low residue homology, the
structure for a LANADBD monomer was very similar to
chain A of EBNA1DBD. The root mean square deviation
(RMSD) was 0.85 A ˚ between the EBNA1DBD structure and
the predicted LANADBD model, suggesting close similarity.
To predict the multimer structure of LANADBD, the program
M-ZDOCK (Pierce et al., 2005) was run using the LANADBD
homology model to perform a full search of possible
homodimeric interfaces. The output models from M-ZDOCK
were then filtered based on similarity to the EBNA1DBD
dimer interfaces, the ability to fit double-stranded DNA and
the score of the model from the program ZRANK (Pierce et al.,
2007). We next selected two M-ZDOCK models for the
LANADBD dimer using these criteria, which were joined to
construct a tetramer (Fig. 2a). The RMSD for the LANADBD
dimer versus the two EBNA1DBD chains was 2 A ˚.
We have shown previously that LANA binds to LBS1/2
within the TRs, which are spaced by 21–22 nt (Garber et al.,
2002),andWong&Wilson(2005)demonstratedthatLANA
occupying both sites induces a bend of about 110u. Whilst
the sequence composition between EBNA1-binding sites
(AT-rich) and LANA-binding sites (GC-rich) is very
different, both the spacing and the induced DNA bending
are conserved features. Accordingly, the DNA conformation
was initially taken from the structure of EBNA1DBD bound
to DNA (Bochkarev et al., 1996) and fitted to the two dimers
in the LANADBD tetramer. The linking DNA between the
two dimer-binding sites was extended from the existing
DNA strands. The Rosetta program (Havranek et al., 2004)
was then used to restore the DNA sequence to the LBS1/2
sequences and repack the LANA side chains accordingly.
The resulting model for the LANADBD tetramer bound to
DNA (Fig. 2a) shared the defining b-barrel core domain
structure with both EBNA1DBD and E2DBD. The dimer of
LANADBD was composed of eight antiparallel b-strands
within their core domains, and flanking domains including
helices 1 (Fig. 2a in red) (Bochkarev et al., 1995), which were
positioned at the outside of each monomer towards the
dimer interfaces. The b-barrel formation was composed of
four b-strands from each monomer, and the b-strands were
connected by crossover of the two a-helices (within each
core domain) (Fig. 2a in blue and green) on the outside of
each barrel. Hence, our model incorporated all known data
on the LANADBD–DNA interaction (Garber et al., 2002;
Wong&Wilson,2005),andsuggestedsimilarsecondaryand
quaternary structures for LANADBD and EBNA1DBD.
S.-J. Han and others
2204 Journal of General Virology 91Mutagenesis of KSHV LANADBD and expression of
mutant proteins
To test the LANADBD model, we performed a detailed
mutational analysis by targeting conserved residues in the
three a-helices and the proline loop. A total of 38 single,
double or triple alanine substitutionmutantswere generated
by site-directed mutagenesis. Wild-type (wt) and mutant
proteins were expressed using the modified vaccinia virus
Ankara (MVA)/T7 RNA polymerase expression system in
(a)
(b)
RFHVMn 899 RRVPGGNGG R PPF HARFQS P MMPYQT PDG C PPK ARPLHR F YLRFLGPL - -
−−− − −−−+ −− G −− PK + −−−− − −+ −−L+− +
EBV 461 - - - - - - - - - - - - - - - -KGG W FGKHRGQGG S NPK F ENI AE G LRALLARSH V
10 20 30 40 50
RFHVMn 947 T M Y R P D R H W R H A A I F W T P R P Y P L K K M A Q --A L Q F G G I R C G P V T C L - - - --
− +++−−+ − W −− ++ + +−− − −+L+− + − +A L − ++−−R − +P − ++L
EBV 495 ERTTDEGTW V AGVFVYGGS K TSLYNLRRG T ALA I PQCRL T PLSRLPFGM A
60 70 80 90 100
RFHVMn 990 --P H P GRPG VP G P H M Y C I YVY C Q S K A T A QKV I L G R E A W EAN H G A . A V I LE
P − P −−−− −− − − + − + −− V+ − Q+−−− A −−++− + − + −−− − −−+A +− +
EBV 545 PGPGPQ P G P L RES I VCYFM V FLQTH I FAE V LKDA IKDLV M TKPAPTCNI R
110 120 130 150
RFHVMn 1037 SSRVKF KD S - -MP L NLGSL P PPAPT S PPH S NASQETE
− + − +F+D+ +P
EBV 595 V T V C S FDDG V D L P- ----- - ----- - --- - --- - ---
160 170 180
RRV 301 QQPARP PR P P RPPRYPIPI P YPSSE E EVP R KYRPQRRFY R QVLGPRIDP P
−−−−−−−−− − −−−S −−−−− − − ++R +− + −−−++ +
EBV - - - - - - - - - - KGGWFGKHR G QGGSN P KFE N I AEG LRALL A R- -SHVERT T
10 20 30 40 50
RRV 351 RPGPWCHG V I FCN S DPYSL Y RLAR- - CLQ F PGI R ASSVR V LP - - - - -DA P
−−G − W −−GV +++−−−− SL Y − L − R+ L − +P −−R − ++++ + LP ++ +
EBV 499 DEGTWV AG V F VYGGSKTSL Y NLRRG T ALA I PQCR LTPLS R LPFGMAPGP G
60 70 80 90 100
RRV 394 GSPVI - - - - P AFC I TVFCQ S RGTAK A VKK A RRRWERHHP S -APHFQASI V
+ − P++ + +− + −− VF− Q+−−−A − +K− A − + −−−−−− P+ + − + − ++ −
EBV 549 PQPGP L R E S I VCY FMVFLQ T HI FAE V LKD A I KD L VMTKP A PTCNIRVTV C
110 120 130 140 150
RRV 439 RMDRG - - L P I QH
++D+G LP
EBV 599 SFDDGVD L P - - -
160
140
KSHV 835 (994) RPGVRMRR V P VTHP KKPHP R YQQPP V PYR Q IDDCPAKAR P QHI FYRRFL G
−−− − −−−−−−−−− −−+ −−−− A+ − ++− +R −
EBV 461 ------ - - - - --- - --K G GW F G K H RG Q G G S N P KFE NIA E G L R A L L A R-- S
10 20 30 40 50
KSHV 885 (1044) KDGRRDPKC Q WKFAVIFW G N DPYGL KKLS Q - -AFQFGGV K AGPVSCL- - -
− + − R − + −−+ − W −−+V ++ G −− − − +L+ − L − +A + − ++−− + − +P+S+L
EBV 493 HVERTTDEG T WVAGVFVYG G SKTSL YNLR R GTA L AIPQC R LTPLSRLPF G
60 70 80 90 100
KSHV 930 (1089) -- PHPGP D Q S P - - - - I TYC V YVYCQNKDT S KKVQMARLA W EASHPL -AG N
P + P G P − ++ P I+− + −− V+− Q+−−− + −−++− A − + −−− − − − P − + − N
EBV 543 MAPGPG P Q P G P LRE SIVCY F MVFLQT HI F A EVL KDAIKD L VMTKPAPTC N
110 120 130 140 150
KSHV 973 (1132) LQ SSIVKFK K P-- LPLTQ P G EN Q G PGDSP Q
+ − ++− +F+ − +L P
EBV 593 IR V T V CSFD D G V DLP---- - ----- - --- -
160 170 180
KSHV vs EBV
RFHVMn vs EBV
RRV vs EBV
461
P
KSHV 775 (934) - -EEPI I L H G SSS EDEMEV D YPVVS T HEQ I ASS P PGDNT P DDDPQPGPS R EY
RFHVMn 849 ------ - - - - ---QE P E D S D N A D A NTQ E P S E V NEP---V P -P E P E S N P E P S Y
RRV 251 HTSHSY T V G G WGP P TRAG- G VPCLR L RCT S HNS - - - - - - - - -HEDEAPE R QQ
10 20 30 40 50
PR R P P KR P F Y
KSHV PHRPGV RMR R VPV T HP- -K K PHPRYQQPP V PYRQ IDDCP A KARPQHI FY R RF
RFHVMn P-RPVVR L R R VPGGNGGRP P FHARFQSPM M PYQT PDGCP P KARPLHRFY L RF
RRV Q-QPARP P R P - - - - - - - - - P RPPRY P IPI P YPS S EEEVP R KYRPQRRFY R QV
70 80 90 100 110
W IF P YL Q F G V LP
KSHV PKCQWK F A V I FWGNDPYGL K KLSQA FQFG G VKAGPVSCL P HPGPD- -QS P I T
RFHVMn PDRHWRH A A I FWT P RPYPL K KMAQA L QFG G IRCGPVTCL P HPGRPGVPG P HM
RRV RPGPWCHG V I FCN S DPYSL Y RLARC L QFP G IRA S SVRVL P DAPGS- -PV I PA
T VR WE H AS V P
KSHV NKDTSK K V Q M ARL AWEASH P LAGNL QSSI V KFK K PLPLT - - - - -QPGEN Q GP
RFHVMn SKATAQK V I L GRE AWEANH G AAVI L E SSR V KFKDSMPLN L GSLPPPAPT S PP
RRV S R G T A KAVK K A R RR W E R H H P S A P H FQA SI V R M DRG L PIQ H --------- - --
KSHV ---
RFHVMn E--
RRV ---
140 150 160 170
1071
448
130
1003 (1162)
220 210 190 200 230
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AVINVDS G
EQEGEER Q
60
L G
LGKDGRR D
LGPLTMY R
LGPRIDP P
120
CV C Q
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FCI TVFC Q
180
GDSPQEM T
HSNASQE T
------- -
240
Fig. 1. Sequence alignments of LANADBDs of gammaherpesviruses and EBNA1DBD reveals structural conservation. (a)
Multiple alignments of amino acid sequences among LANADBDs of KSHV, RFHVMn and RRV using the PRALINE and T-Coffee
programs. Conserved amino acids among the OBPs are labelled in bold above the sequences. (b) Binary amino acid alignments
between EBV EBNA1DBD and the LANADBDs of KSHV, RFHVMn and RRV using the 3D-PSSM program. Conserved helices
among the proteins are shown as shaded dark grey boxes. Proline loops are indicated in italic within light grey boxes. Numbers
in parentheses refer to corresponding amino acid numbers from BC-1 KSHV LANA (Kelley-Clarke et al., 2007). Short dashes
indicate missing amino acids; + and ” indicate similarity or no similarity between amino acids.
Structure–function analysis of KSHV LANA DBD
http://vir.sgmjournals.org 2205CV-1 cells as described previously (Garber et al., 2001,
2002). Briefly, constructs containing T7 promoter were
transfected into MVA/T7-infected cells. The cells were
harvested 36 h post-transfection and the proteins were
enriched by affinity purification. Expression levels for all
mutant proteins were monitored by Western blotting (see
Supplementary Fig. S1, available in JGV Online).
Evaluation of wt and mutant KSHV LANADBDs for
DNA binding by electrophoretic mobility shift
assay (EMSA)
We reported previously that LANADBD binds to its high-
affinity binding site (LBS1) with a Kd of 1.51±0.16 nM
(Garber et al., 2002). To determine the effect of mutations
on DNA binding, equal amounts of wt and mutant
LANADBD proteins were incubated with radiolabelled
probes containing either LBS1 or LBS1/2 (Fig. 3). After
electrophoresis, the gels were dried and signals were
quantified by phosphoimaging. Representative autoradio-
graphs from three independent experiments are shown.
Table 1. Similarity and identity of the C termini among
gammaherpesvirus OBPs
Amino acid similarity (identity) (%)
KSHV RRV RFHVMn EBV
KSHV 100 – – –
RRV 53 (30) 100 – –
RFHVMn 54 (40) 46 (26) 100 –
EBV 53 (14) 43 (16) 30 (13) 100
Fig. 2. Computational model of the LANADBD
and multimer structure bound to DNA. The
figure shows the LANADBD model with the
specific DNA-binding site predicted by the M-
ZDOCK program based on alignment with the
structure of EBNA1DBD. (a) The tetramer
formed by combining two dimers bound to
their respective LBS1/2 (DNA helix in light
blue and green). The b-barrel bundle is made
of four b-strands from each monomer at the
dimer interface. (b) Each monomer is com-
posed of four b-strands and three helices (helix
1 in red, helix 2 in blue and helix 3 in green).
(c, d) Crucial amino acids for DNA contact or
dimerization are shown in yellow:
871K and
875Q for helix 1,
963W and
964E for helix 3 (c)
and
907Y,
910K and
911K for helix 2 (d). The
monomer pictures were generated using
ViewerLite 4.2 (Accelrys).
S.-J. Han and others
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(b) Proline loop
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Fig. 3. DNA-binding activity of LANADBD
mutants. Purified LANADBD wt and mutant
proteins were incubated with radiolabelled
LBS1 or LBS1/2 as described previously
(Garber et al., 2001). The DNA-binding affinity
is represented as the percentage for mutants
compared with wt LANADBD, which was set to
100%. In each assay, all mutants were tested
for DNA-binding activity with LBS1 (a–c) or
LBS1/2 (d). EMSA results are shown for helix
1 mutants (a), helix 2 mutants (b), helix 3
mutants (c) and adapted mutants from each
helix (d). Arrows indicate specific protein–DNA
complexes. NC, Probe alone as a negative
control; wt, wt LANADBD. Results on graphs
are shown as means±SD from three inde-
pendent experiments.
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affinity to both LBS1 and LBS1/2 (Fig. 3a, d). In particular,
P874A and H876A reduced the DNA-binding affinity to
less than 20% of that of wt (Fig. 3a, lanes 5 and 8). Helix 1
(
871K–
882F) contains the polar residues
871K,
873R and
879Y,
which are highly conserved residues among KSHV,
RFHVMn and RRV (Fig. 1a). These residues potentially
contact DNA either directly or indirectly by stabilizing the
secondary structure of the N-terminal domain of
LANADBD. From the structure of EBNA1DBD, polar residue
477K within helix 1 and residues
461K–
469R within the N
terminus have been shown to contact DNA directly
(Bochkarev et al., 1996). In agreement with the binding
data, the predicted structure (Fig. 2) suggested that the N-
terminal residues of helix 1 (
871K,
873R and
875Q) are
located in close approximation to the DNA (Fig. 2b, c). For
EBNA1DBD, residues within helix 2, which was originally
termed the DNA recognition helix (Bochkarev et al., 1995),
also contribute to DNA binding. The recognition helices of
all HPV E2 proteins contain several highly conserved
residues in a consensus motif (
338LXXLRY
343), which is
also conserved in EBNA1DBD (
517LYNLRR
522) (Fujita et al.,
2001). Within LANADBD,
906PYGLKK
911 in helix 2 has a
similar surface charge to EBNA1DBD helix 2 (Fig. 1).
Moreover, in the model,
907Y and
910KK
911, like
518Y and
521RR
522 of EBNA1DBD, were predicted to be in close
contact with the DNA (Fig. 2d). Indeed, all mutants in
helix 2, except L909A, showed dramatically reduced DNA-
binding affinities to both LBS1 and LBS1/2 (Fig. 3b, d).
For EBNA1DBD, it was shown that the proline loop
(
545PGPGPQPGP
553) between helix 2 and the b-barrel
bundle contributes to DNA binding as well as to protein–
protein interactions with cellular transcription factors
(Bochkarev et al., 1995, 1996). Mutant P932A in the centre
of the proline loop (
930PHPGPDQSP
938) of LANADBD did
not reduce DNA-binding affinity (Fig. 3b, lane 13);
however, P925A located inside the b-barrel bundle reduced
binding affinity by about 50% (Fig. 3b, lane 12).
Helix 3 (
950K–
966S) followed the proline loop and
continued towards the inside of the b-barrel through an
extended strand. In contrast to mutants in helices 1 and 2,
helix 3 mutants, except for SKK953AAA, L961A, W963A
and WE963AA, did not show significant changes in DNA-
binding affinity (Fig. 3c, d and Table 2). SKK953AAA in
helix 3 may change folding by interrupting hydrogen bonds
with basic residues of helix 1. Thus, these helix 3 residues
contribute towards stabilizing protein–DNA interactions
and, in contrast to residues within helices 1 and 2, are not
directly involved in DNA binding.
Evaluation of multimerization of KSHV LANADBD
by co-immunoprecipitation assays
Schwam et al. (2000) first demonstrated that LANADBD in
solution and in the absence of TR DNA exists predomi-
nantly as a homodimer. To analyse dimerization of a subset
of mutants with reduced DNA-binding activities, we
performed co-immunoprecipitation assays. Flag-tagged
wt or mutant LANADBDs were tested for their ability to
interact with haemagglutinin (HA)-tagged wt LANADBD.
LANADBD complexes were immunoprecipitated by anti-
Flag beads and separated by SDS-PAGE. The amount of wt
LANADBD precipitated was detected and quantified by
Western blotting using anti-HA antibody. The dimeriza-
tion activity for each mutant is reported as the percentage
relative to that of HA- and Flag-tagged wt LANADBD,
which was set to 100%.
Mutants HIF876AAA and YR879AA in helix 1, which
showed drastically reduced DNA-binding affinities, did
dimerize at a level comparable to wt (Fig. 4a, lanes 5–8).
RF881AA and Q875A reduced dimerization only (Fig. 4b,
lanes 5 and 6, and Table 2), further suggesting that most
helix 1 residues contribute directly to DNA binding but not
to dimer formation.
Similarly, except for YGL907AAA, which showed a
moderate decrease (73%) in dimerization (Fig. 4b, lanes
7 and 8), helix 2 mutants had largely unaltered or increased
dimerization activities compared with wt (Fig. 4c, lanes
5–8). This result was expected, as helix 2 of EBNA1DBD and
presumably LANADBD function as a DNA recognition
domain. In addition, P925A within the b-barrel connected
to the proline loop did not affect dimerization (Table 2).
Within helix 3, several mutants had reduced dimerization
(Fig. 4d–f). Dimerization for WE963AA and SKK953AAA
was reduced to 29 and 64%, respectively (Fig. 4f, lanes 7
and 8, and Table 2). Within the EBNA1DBD, the
corresponding mutants in helix 3 showed the loss of both
dimerization and DNA replication activities (Bochkarev
et al., 1996).
Analysis of DNA replication activity of wt and
mutant KSHV LANADBDs
Mutagenesis of the LBS1/2 showed that the replication
efficiency of TR-containing plasmids is dependent on the
LBS1 (Garber et al., 2002). To test the inverse, we chose a
subset of mutants with reduced DNA binding or
dimerization and performed transient replication assays
as described previously (Garber et al., 2002; Hu et al.,
2002). Briefly, a plasmid containing four copies of the TR
was co-transfected with plasmid expressing wt or mutant
LANADBD into 293 cells. Replicating DNA was extracted
and analysed by Southern blotting after DpnI digestion. As
described previously, LANADBD replicated with about 20%
efficiency compared with full-length LANA (compare
Fig. 5a, lanes 9–11, and Fig. 5b, lanes 7–9) (Hu et al.,
2002).
The mutants with reduced binding affinity in helix 1
(HIF876AAA and YR879AA), helix 2 (YGL907AAA,
KK910AA and LSQ912AAA) and helix 3 (SKK953AAA)
did not replicate to detectable levels (Fig. 5a, lanes 12–15,
and b, lanes 10 and 11). Furthermore, WE963AA in helix 3,
which strongly reduced dimerization, was also inactive in
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which had no phenotype in either binding or dimerization,
showed residual replication activity (Fig. 5a, lane 16).
These data further confirmed that LANA dimerization and
high-affinity binding to the TR are required for replication.
Interestingly, whilst the proline loop mutant P932A bound
to DNA and dimerized like the wt, it did not support
replication (Table 2 and data not shown). For EBNA1DBD,
it has been shown that the proline loop contributes to
spatial orientation of helices 1 and 2 and interacts with
cellular proteins (Bochkarev et al., 1995, 1996; Ceccarelli &
Frappier, 2000).
Table 2. Summary of LANADBD mutants and their relative activities in DNA binding, dimerization, replication and transcription
repression
NT, Not tested.
Position Mutant EMSA* IPD RAd Repression assay§
LBS1 LBS1/2
Helix 1 K871A 74 (±4.8) 35 (±2.2) 74 NT 79 (±8)
R873A 48 (±2.9) 18 (±1.6) 135 NT 103 (±12)
P874A 19 (±1.3) 21 (±2.1) 98 NT 77 (±13)
Q875A 40 (±2.5) 8 (±2.02) 57 NT 87 (±11)
HIF876AAA 28 (±1.9) 3 (±1.85) 127 2 41 (±7)
H876A 14 (±1.6) NT NT NT 66 (±5)
I877A 21 (±2.4) NT NT NT 65 (±6)
F878A 32 (±1.8) NT NT NT –
YR879AA 26 (±1.5) 5 (±2.11) 73 2 67 (±8)
Y879A 29 (±2.2) NT NT NT 75 (±4)
R880A 55 (±3.4) NT NT NT 7.4 (±0.6)
RF881AA 61 (±3.5) 15 (±2.54) 31 NT NT
R881A 64 (±3.6) NT NT NT NT
F882A 48 (±2.6) NT NT NT NT
Helix 2 YGL907AAA 23 (±7.8) 25 (±3.01) 73 2 –
Y907A 10 (±2.8) NT NT NT 71 (±6)
L909A 74 (±0) NT NT NT NT
KK910AA 34 (±2.1) 5 (±2.29) 210 2 NT
K910A 21 (±6.5) NT NT NT NT
K911A 11 (±2.8) NT NT NT NT
LSQ912AAA 28 (±3.6) 19 (±2.97) 248 2 50 (±3)
F916A 52 (±2.1) NT NT NT NT
Q917A 32 (±6.3) NT NT NT NT
P925A 51 (±3.5) 20 (±2.3) 200 NT 72 (±7)
Proline loop P932A 99 (±2.1) NT NT NT 83 (±6)
Helix 3 KDT950AAA 112 (±16) NT 74 NT 93 (±9)
SKK953AAA 33 (±18) 54 (±3.82) 64 NT 65 (±11)
VQM956AAA 71 (±13) 77 (±4.1) 88 NT NT
V956A 108 (±9) NT NT NT NT
Q957A 138 (±13) NT 147 NT 86 (±5)
M958A 146 (±18) NT NT 94 (±2)
RL960AA 97 (±14) 91 (±3.87) 104 NT NT
R960A 106 (±11) NT NT NT NT
L961A 59 (±7.8) NT NT NT 69 (±6)
WE963AA 65 (±11.5) 56 (±3.33) 29 2 0.2 (±4)
W963A 70 (±12) NT NT NT 64 (±4)
E964A 104 (±9.1) NT NT NT 94 (±7)
S966A 136 (±16) 127 (±4.6) 188 +/2 82 (±13)
*Detection levels by EMSA in the presence of a single or double DNA-binding site. Numbers indicate the percentage of relative binding affinity
compared with that of wt.
DIP, Detection levels by immunoprecipitation. Numbers indicate the percentage of dimerization activity compared with that of wt.
dRA, Replication activity. –, No activity; +/2, reduced activity compared with that of LANADBD.
§Transcription repression activity. Numbers indicate the percentage of transcriptional repression activity compared with that of wt.
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mutant LANADBDs
We and others have previously shown that the TR sequences
have enhancer activity, which can be repressed by LANA.
Furthermore, LANADBD alone is sufficient for repression
(Garber et al., 2001). To test mutants for repressor activity,
plasmids encoding wt or mutant LANADBD were co-
transfected with pGL3/7TR reporter plasmid into 293 cells.
Cell lysates were assayed for luciferase activity and normal-
ized as described previously (Renne et al., 2001). The data
for mutants in all three helices is shown as the percentage
repression activity compared with that of wt, which was set
to 100% (Fig. 6).
Within helix 1, eight out of 11 mutants had only moderately
decreased repression activity of between 80 and 65%
compared with wt. Repression activity of HIF876AAA and
F878A was decreased to 41% and to less than 1% of wt,
which was concordant with strongly reduced binding
activity (Fig. 6a and Table 2). Interestingly, R880A showed
only 7% repression activity despite its DNA binding activity
only being reduced to 55% (Fig. 6a and Table 2).
Within helix 2, four out of five tested mutants showed
significantly decreased repression activity, the exception
being Y907A. These were mostly concordant with either loss
of or a strong reduction in DNA binding (Table 2). These
data further confirmed that residues in helix 2 significantly
contribute to DNA recognition and binding. Interestingly,
the DNA binding of Y907A was strongly reduced, although
it displayed 71% repressor activity (Fig. 6b).
In agreement with the DNA-binding data, most mutants in
helix 3, including the proline loop, had a modest or no
(a)
(b)
(c)
(d)
(e)
(f)
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(Helix 1)
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(Helix 3)
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100 %               31 % 73 %
100 %              210 %             248 %
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 100 % 88 %
   104 %   29 % 100 %
     1           2           3          4           5         6         7          8
L         IP         L         IP          L         IP         L         IP
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KDT950AAA Q957A
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Fig. 4. Co-immunoprecipitation assays with alanine substitution
mutants. The dimerization ability of Flag-tagged wt or mutant
LANA
DBD
s with HA-tagged wt LANA
DBD
was tested. Dimerization
activity for each mutant was normalized based on the expression
level of Flag-tagged wt or mutant LANA
DBD
proteins. L, Cell lysate,
IP; immunoprecipitated samples; Wt (N), HA-tagged wt only as a
negative control; Wt (P), Flag-tagged and HA-tagged wt as a
positive control.
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Input DNA Replicated DNA Input DNA Replicated DNA
Fig. 5. Analysis of DNA replication mediated by alanine substitution mutants using a short-term replication assay. LANADBD-
expressing constructs were co-transfected with pPuro/4TR into 293 cells; 10% of the extracted DNA (Hirt, 1967) was
digested with HindIII as input (a, lanes 1–8, and b, lanes 1–6) and the remaining DNA was double digested with HindIII and
DpnI (a, lanes 9–16, and b, lanes 7–12). The DNA was detected by Southern blotting with a radiolabelled 4TR probe. Full-
length LANA was transfected as a positive control. The arrow indicates the position of full-length pPuro-4TR.
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WE963AA completely abolished repressor activity.
Interestingly, although WE963AA had only modestly
reduced DNA-binding activity (Table 2), it had strongly
reduced homodimer formation, suggesting that these
residues may interact with helix 1 to stabilize the
homodimer or contribute to interactions with cellular
proteins conveying transcriptional repression.
In summary, these data showed that, for most of the
mutants, DNA binding and transcriptional repression were
similarly affected. However, we observed some mutants,
notably R880A and WE963AA, that could bind to the TR
but did not repress transcription, and one mutant, Y907A,
that bound poorly to theTRbut stillrepressed transcription.
DISCUSSION
Many mechanistic details on the role of LANA in
transcriptional regulation, latent DNA replication, tether-
ing of viral episomes to host chromatin and interaction
with multiple host cellular proteins have been reported
(reviewed by Lieberman et al., 2007; Verma et al., 2007). In
contrast, with the exception of a small 23 aa peptide in the
N-terminal histone H2A-binding domain (Barbera et al.,
2006), no structural data is available on LANA. We have
expressed LANADBD protein using vaccinia virus, baculo-
virus and Escherichia coli systems, but have not yielded
concentrations of soluble protein amenable to crystalliza-
tion. A further complicating factor is that all published
DNA-binding assays have been performed in the presence
of BSA, substitution for which will be crucial to solve the
LANADBD structure in the presence of its cognate binding
site (Ballestas & Kaye, 2001; Cotter & Robertson, 1999;
Garber et al., 2002).
In the meantime, we performed bioinformatics modelling
based on the observed sequence homology between the
DBDs of KSHV, RRV and RFHVMn LANA and the DBD
of EBNA1 to predict a structure for KSHV LANADBD.W e
note that the X-ray structures of the EBNA1DBD and E2DBD
core domains, which show no discernible sequence
homology, superimpose almost perfectly (Bochkarev et al.,
1996; reviewed by Grossman & Laimins, 1996; Hegde et al.,
1992; Liang et al., 1996). In contrast, the DBDs of LANA
and EBNA1 showed 14% identity and 53% similarity
(Table 1) and the highest conservation was within motifs
that are crucial for the overall core domain structure (Fig.
1b) (Grundhoff & Ganem, 2003). As a result, the predicted
model (Fig. 2) indicated a high degree of structural
relatedness.
To functionally validate this model, we targeted the three
a-helices and the proline loop, which showed the highest
conservation (Fig. 1b) and for which phenotypes have been
described for EBNA1DBD. We identified residues in all three
a-helices that are crucial for DNA binding (helices 1 and 2)
or multimerization (helix 3). Both efficient DNA binding
and dimerization are crucial for LANA’s ability to support
replication of the TR-containing plasmids. The functional
data for all mutants is summarized in Table 2. The key
observations were that charged residues within a conserved
motif in helix 2 (
906PYGLKK
911) were crucial for DNA
binding (Fig. 2d). Helix 1 of LANA DBD also contributed to
binding, presumably through direct interactions with DNA
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Fig. 6. Analysis of the activity of LANA-dependent transcriptional
repression by alanine substitution. Graphical representation of
data from luciferase reporter assays. pGL3/7TR luciferase reporter
and wt or mutant LANADBD plasmid were co-transfected. RLU
values were normalized to total protein concentration as described
previously (Renne et al., 2001). The percentage of suppression
activity was compared with that of LANADBD wt, which was set to
100%. Results are shown as means±SD from three independent
experiments. (”)LANA, Negative control with no LANADBD.
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EBNA1DBD where helices 1 and 2 both significantly
contribute to DNA binding. Interestingly, within the crystal
structure, helix 1 of EBNA1DBD was located much closer to
the DNA than helix 2. However, biochemical data by
Cruickshank et al. (2000)clearly demonstrated that helix 2 is
also critical for DNA binding. To explain the difference
between the crystal structure of EBNA1DBD bound to DNA
andthebiochemicaldata,itwassuggestedthatEBNA1binds
to DNA via a two-step mechanism: sequence-specific
binding is initiated by helix 2 followed by interactions of
helix 1 residues. The observation that LANA residues from
both helices contribute to binding activity points to a
conserved DNA-binding mechanism for EBNA1 and the
rhadinovirus LANA proteins, which has also been suggested
for the HPV E2 protein (reviewed by de Prat-Gay et al.,
2008; Hegde et al., 1992; Liang et al., 1996).
Most mutations in helices 1 and 2 reduced transcriptional
repressor activity as well as reducing DNA binding (Table
2). These data are consistent with the previous observation
that high and low affinities of LBS1/2 determine DNA
binding and replication (Garber et al., 2002). In contrast,
most mutants in helix 3 had only moderate effects on
transcriptional suppression; however, mutant WE963AA
displayed greatly reduced repression but only moderately
reduced DNA binding (Fig. 3c and Table 2), indicating a
role in protein–protein interactions that conveys LANA-
dependent repression.
These data strongly suggest functional homology between
all three a-helices and the proline loop of KSHV LANADBD
and EBNA1DBD. In addition, this analysis yielded at least
one mutant in each helix and in the proline loop that
showed discordance in phenotype with regard to DNA
binding, homodimer formation, transcriptional repression
or DNA replication. Within helix 1, R880A bound to the
TR but had almost no repressor activity. Conversely,
Y907A in helix 2 significantly reduced DNA binding but
still repressed transcription, and WE963AA in helix 3 had
only moderately reduced binding but completely lost
repression activity. Finally, proline loop mutant P932A
had no defect in either binding or dimerization, but did
not support DNA replication. These mutants will be useful
for further mechanistic studies on LANA function and
some may function as dominant-negative proteins, which
have not been described to date for LANA.
Previously, two studies have performed mutational analysis
of the LANA C-terminal domain. First, Wong & Wilson
(2005) introduced a limited set of mutations and analysed
their effect on DNA binding and found that binding to DNA
induced 57u bending or greater for LBS1 and about 110u for
occupation on LBS1/2; furthermore, mutations preventing
bending also greatly affected DNA binding of LANA. We
observed similar results for mutants SKK953AAA and
WE963AA in helix 3, confirming that changes in DNA
bending do contribute to decreased DNA binding and
replication activity (Wong & Wilson, 2005). Additionally,
Kelley-Clarke et al. (2007) performed an unbiased muta-
tional analysis across LANADBD by introducing triple
alanine substitutions to define residues important for
binding to the TR and attachment to host chromatin.
With respect to the importance of helix 2 for DNA
recognition, our data are in agreement with both previous
studies and add further details by identifying several
residues whose mutation alone eliminates DNA binding. In
particular,
909L,
910K,
911K and
917Q partly overlap with the
conserved LXXLRY motif present in the core domains of
EBNA1 and many HPV E2 proteins (Fujita et al., 2001).
With respect to helices 1 and 3, we identified several residues
that contribute to DNA binding but were not identified
previously (Kelley-Clarke et al., 2007). Specifically,
HIF876AAA, YR879AA and all corresponding single amino
acid substitutions showed drastically reduced DNA binding
(Figs 3 and 4 and Table 2). In agreement with our
observation, the corresponding EBNA1DBD residues are also
important for DNA binding and bending, either by
contacting the DNA directly or by stabilizing the N-terminal
domain of DBD (Bochkarev et al., 1996). No significant
changes in DNA binding were observed within helix 3
mutants. However, RL960AA, which was previously shown
not to bind to DNA (Kelley-Clarke et al., 2007), bound to
LBS1 or LBS1/2 with wt activity levels (Fig. 4) and also
formed dimers. Observed differences between the two
studies may in part be due to differences in protein
expression and purification method utilized.
In summary, our data suggest that LANADBD has a high
degree of structural conservation with EBNA1DBD, which is
critical for sequence-specific DNA binding, multimer
formation, protein–protein interactions required for its
DNA replication activity and LANA-dependent transcrip-
tional repression.
METHODS
Amino acid alignment of gammaherpesviruses LANADBDso f
different primate species and EBNA1. The sequences of KSHV
LANADBD (aa 775–1003; NCBI Protein accession no. AAK50002), the
reference BC-1 KSHV LANA (aa 934–1162; NCBI Protein accession
no. AAC55944), EBV EBNA1DBD (aa 461–641; NCBI Protein
accession no. P03211), RFHVMn LANADBD (aa 849–1071; NCBI
Protein accession no. ABH07414) and RRV LANADBD (aa 251–448;
NCBI Protein accession no. AAF60071) were binarily and multiply
aligned using 3D-PSSM version 2.6.0 (http://www.sbg.bio.ic.ac.uk/
servers/3dpssm/index.html), PRALINE (http://www.ibi.vu.nl/programs;
reviewed by Pirovano & Heringa, 2010) and T-Coffee version 7.71
(http://www.tcoffee.org/; Notredame et al., 2000).
Computational prediction of the LANADBD multimer structure.
The M-ZDOCK program (http://zlab.bu.edu/m-zdock) was used to
predict putative LANADBD dimer and tetramer complexes. M-ZDOCK
is a specially developed algorithm for predicting the structure of
multimers based on the structure of unbound (or partially bound)
monomers (Pierce et al., 2005). The predicted tetramer of LANADBD
bound to LBS1/2 was modelled based on solved structures of
EBNA1DBD (Bochkarev et al., 1996).
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previously (Garber et al., 2001). Fragments containing LBS1 or LBS1/
2 used as EMSA probes were produced by XhoI/XbaI digestion from
pAG31 containing LBS1 and pAG43 containing LBS1/2, respectively,
as described previously (Garber et al., 2002).
pPuro/4TR, used for the short-term replication assay, was constructed
by cloning four TR units from pCRII/4TR (Garber et al., 2002; Hu
et al., 2002) into a pPur vector (BD Biosciences). PGL3/7TR, which
contains seven TR units, was constructed from pAG9 (Garber et al.,
2001) and used as a reporter for LANA-dependent transcriptional
repression assays.
Alanine substitution mutagenesis. A PCR-based QuikChange
Site-directed Mutagenesis kit (Stratagene) was used to generate
alanine substitution mutants in LANADBD, as recommended by the
manufacturer. Primers containing the desired alanine substitution
were designed using the web-based program Primer X (http://
bioinformatics.org/primerx) (see Supplementary Table S1, available
in JGV Online). All constructs were confirmed by sequencing (Davis
Sequencing Co.).
Cell lines. CV-1 cells, African green monkey fibroblasts, 293 cells,
human embryonic kidney cells, were obtained from ATCC. Cell
monolayers were maintained in Dulbecco’s modified Eagle’s medium
supplemented with 10% fetal bovine serum, 2 mM L-glutamine, 5 U
penicillin ml
21 and 5 mg streptomycin ml
21 (all from Mediatech) at
37 uC under a 5% CO2 atmosphere.
Expression of wild-type and mutant LANADBD proteins with the
MVA/T7 expression system. Wild-type and mutant LANADBD
proteins were produced by using an MVA/T7 expression system
(Moss et al., 1990). Briefly, highly confluent CV-1 cells in 10 cm
plates were infected with MVA/T7 virus as described previously
(Garber et al., 2001; Moss et al., 1990) and transfected at 3 h post-
infection using a slightly modified calcium phosphate methods
(Sambrook & Russell, 2001). Cells were harvested at 36–40 h post-
transfection. His-tagged wt or mutant LANADBD proteins were
purified using Ni
2+/Tris(carboxymethyl)ethylenediamine columns
(Active Motif). Protein concentrations were determined by BCA
assays (Bio-Rad) and protein expression levels were determined by
Western blot analysis using anti-Flag M2 antibody (Sigma-Aldrich).
EMSA. For probe labelling, fragments containing LBS1 or LBS1/2
were labelled using T4 polynucleotide kinase (NEB) in the presence of
[c-
32P]ATP (Amersham Biosciences) following the manufacturer’s
instructions. EMSAs were performed as described previously (Garber
et al., 2001). Captured protein–DNA complex signals on the
phosphor screen were analysed using a Typhoon 9410 phosphor-
imager system (Amersham Bioscience).
Co-immunoprecipitation. Plasmids expressing wt and mutant Flag-
tagged LANADBD proteins and a plasmid expressing wt HA-tagged
LANADBD were co-transfected to evaluate dimer formation. Co-
transfected cells were harvested at 36–40 h post-transfection, lysed in
lysis buffer and pre-cleared by centrifugation. Lysates were co-
immunoprecipitated with anti-Flag M2 beads. LANADBD complexes
were separated by SDS-PAGE and the amount of HA-tagged wt
LANADBD was detected and quantified by Western blotting using
anti-HA antibody. Dimerization activity for each mutant was
normalized based on the expression level of Flag-tagged wt or mutant
LANADBD proteins.
Short-term DNA replication assays. Co-transfection of 3610
6 293
cells with 8 mg pPuro/4TR plasmid and 2 mg wt or mutant LANADBD
expression plasmids was carried out using TransIT-293 Transfection
Reagent (Mirus). Transfection efficiency was monitored using
pcDNA3/LacZ. Short-term DNA replication assays were performed
as described previously (Hu et al., 2002). Captured signals on the
phosphor screen were analysed using a Typhoon 9410 phosphor-
imager system.
Luciferase reporter assays. For transcriptional repression assays,
20 ng pGL3/7TR luciferase plasmid as a reporter and 380 ng wt or
mutant plasmid as an effector were co-transfected into 3610
5 293
cells using TransIT-293 Transfection Reagent. To monitor transfec-
tion efficiency, pMaxGFP plasmid was co-transfected with these
plasmids and transfection efficiency was over 90%. Relative light
units (RLUs) were measured at 48 h post-transfection. Protein
concentrations were determined by BCA assay, and RLU values were
normalized to the protein concentration. This was based on previous
observations that LANA modulates a wide range of promoters
(Renne et al., 2001). Reporter gene activity values represented the
mean of several independent transfections performed in triplicate
(means±SD).
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